Development of an efficient transdermal delivery system of small interfering RNA using functional peptides, Tat and AT-1002.
about
Nucleic acid delivery into skin for the treatment of skin disease: Proofs-of-concept, potential impact, and remaining challenges.Progress toward in vivo use of siRNAs-II(31)P solid-state NMR based monitoring of permeation of cell penetrating peptides into skin.Noninvasive approach for enhancing small interfering RNA delivery percutaneously.Topical Anti-Nuclear Factor-Kappa B Small Interfering RNA with Functional Peptides Containing Sericin-Based Hydrogel for Atopic Dermatitis.Enhanced skin permeation using polyarginine modified nanostructured lipid carriers.Development of an Innovative Intradermal siRNA Delivery System Using a Combination of a Functional Stearylated Cytoplasm-Responsive Peptide and a Tight Junction-Opening Peptide.Dermal microdialysis technique to evaluate the trafficking of surface-modified lipid nanoparticles upon topical application.Cell-penetrating peptides as a novel transdermal drug delivery system.Biomaterials as novel penetration enhancers for transdermal and dermal drug delivery systems.Recent progress in tight junction modulation for improving bioavailability.Recent advances in peptides for enhancing transdermal macromolecular drug delivery.Stratum corneum modulation by chemical enhancers and lipid nanostructures: implications for transdermal drug delivery.Cell-penetrating peptide-modified block copolymer micelles promote direct brain delivery via intranasal administration.Human skin permeation of emerging mycotoxins (beauvericin and enniatins).Advances in the Application and Impact of MicroRNAs as Therapies for Skin DiseaseGetting Drugs Across Biological Barriers.Non-invasive Oil-Based Method to Increase Topical Delivery of Nucleic Acids to Skin.
P2860
Q28085200-AD02E60D-01F8-44F4-B065-74B3A945C5B5Q28255877-08B84C8E-1C42-48B6-8AD9-29442E552829Q34736361-427D7D65-5FA5-46C5-95DD-54F3F5A4A116Q35848069-425BAE85-ADF3-40B6-B805-51EA27619E7BQ36105846-AA4BFD69-86E4-4DFF-B439-3F163DA6CFB6Q36144074-C37C6F4B-E0DE-42CC-BBEF-B1568507933EQ36144984-8F99E768-FF61-49B6-9101-ABB0E5B3F817Q36176209-AEE1E726-E5F4-494E-8DD5-342AF24094E5Q38030731-8DF9A930-0098-4BC0-A274-997501C48B8CQ38114136-407E58E5-52D1-4F71-92B9-2D33AE5556D7Q38190079-E5488F84-E9CC-4658-B9D7-5A79ACA17123Q38697294-94663256-F0C9-40B8-9A15-7B4499E338FCQ39450103-FD3E81FA-3125-4B71-831C-B3A5E587BC10Q39557251-5857B98A-A5D3-41B8-B438-0A7E42FE9F29Q41252565-37CFBE05-E2FD-4711-B299-E2A0BC9D50FBQ42362861-DDAC2CAA-99A3-4819-BEBA-4205B90D6EE2Q48331228-7B48D80D-2359-4D01-AE7A-40BF7399FB8DQ55077860-6DACF3E8-C284-4BE9-A017-04A7A86FF94B
P2860
Development of an efficient transdermal delivery system of small interfering RNA using functional peptides, Tat and AT-1002.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Development of an efficient tr ...... nal peptides, Tat and AT-1002.
@ast
Development of an efficient tr ...... nal peptides, Tat and AT-1002.
@en
type
label
Development of an efficient tr ...... nal peptides, Tat and AT-1002.
@ast
Development of an efficient tr ...... nal peptides, Tat and AT-1002.
@en
prefLabel
Development of an efficient tr ...... nal peptides, Tat and AT-1002.
@ast
Development of an efficient tr ...... nal peptides, Tat and AT-1002.
@en
P2093
P356
P1476
Development of an efficient tr ...... nal peptides, Tat and AT-1002.
@en
P2093
Hiroaki Okada
Takanori Kanazawa
Tamae Uchida
Yuuki Takashima
P304
P356
10.1248/CPB.59.196
P407
P577
2011-01-01T00:00:00Z